Healthcare Services

Neurogenomics Market Forecast Covering Industry Demand And Market Evolution

June 2, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Is The Neurogenomics Market’s Market Value Anticipated To Evolve From 2026 To 2030?

The neurogenomics market has experienced substantial expansion in recent years. Forecasts indicate that it is projected to increase from $1.5 billion in 2025 to $1.72 billion in 2026, achieving a compound annual growth rate (CAGR) of 14.7%. Historically, this expansion was driven by several factors, including developments in genomic sequencing technologies, increased funding for neuroscience research, the rising incidence of neurological disorders, enhanced access to bioinformatics tools, and a surge in academic research collaborations.

The neurogenomics market is anticipated to experience substantial expansion in the coming years. This market is projected to reach $2.98 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 14.7%. This projected growth during the forecast period stems from factors such as the greater integration of genomics into clinical neurology, increased investments directed towards precision neurology, the broadening scope of cloud-based genomic analytics, an escalating demand for customized neurological treatments, and a heightened emphasis on translational neuroscience research. Key trends anticipated for this period encompass the wider adoption of next-generation sequencing within neuroscience, a surge in the application of multi-omics data integration, an increasing need for gene expression analysis in neurological contexts, the expansion of personalized neurological investigations, and a stronger emphasis on studies of brain disorders driven by data.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=25845&type=smp

What Primary Factors Are Fueling The Expansion Of The Neurogenomics Market?

The neurogenomics market is expected to grow due to the increasing prevalence of neurological disorders. These are medical conditions affecting the brain, spinal cord, or nerves, resulting in symptoms such as muscle weakness, seizures, pain, or cognitive difficulties. The rising occurrence of neurological disorders is largely attributable to lifestyle choices like poor diet, insufficient physical activity, persistent stress, and heightened exposure to environmental toxins. Neurogenomics offers a more profound understanding of the genetic basis of brain function and dysfunction, aiding in identifying causes, enhancing diagnosis, and developing targeted treatments for these conditions. For example, in March 2023, the Alzheimer’s Association, a US-based nonprofit voluntary health organization, reported that about 6.7 million Americans aged 65 and older were living with Alzheimer’s dementia, a figure projected to increase to 13.8 million by 2060. Thus, the escalating prevalence of neurological disorders is fostering the expansion of the neurogenomics market.

How Does Segment Analysis Break Down The Neurogenomics Market Structure?

The neurogenomics market covered in this report is segmented –

1) By Offering: Next-Generation Sequencing, Polymerase Chain Reaction, Microarray, Software And Services

2) By Application: Variant Discovery, Research Applications, Target Identification, Transcription Factor Binding Analysis, Functional Studies, Clinical Applications

3) By End User: Pharmaceutical And Biotechnology Companies, Academic And Research Institutes, Hospitals And Diagnostic Laboratories

Subsegments:

1) By Next-Generation Sequencing: Whole Genome Sequencing, Whole Exome Sequencing, Targeted Sequencing, Ribonucleic Acid Sequencing

2) By Polymerase Chain Reaction: Real-Time Polymerase Chain Reaction, Reverse Transcription Polymerase Chain Reaction, Digital Polymerase Chain Reaction

3) By Microarray: Deoxyribonucleic Acid Microarray, Ribonucleic Acid Microarray, Protein Microarray

4) By Software And Services: Data Analysis And Interpretation Software, Genomic Data Management Tools, Custom Services, Cloud-Based Platforms And Reporting Tools

Which Trends Are Contributing To Changes In The Neurogenomics Market?

Leading companies in the neurogenetic testing market are developing innovative offerings, such as whole-genome sequencing, to improve the accuracy and breadth of genetic analysis, allowing for more comprehensive and customized testing for neurological disorders. Whole-genome sequencing (WGS) is a thorough genetic testing approach that involves identifying the complete DNA sequence of an individual’s entire genome. For example, in March 2024, Nucleus Genomics, a US-based company providing genetic analysis, introduced a new DNA analysis product. This platform is designed to provide individuals with a deeper understanding of their genetic predispositions, helping them make informed choices about their health and well-being. Utilizing advanced technology and expert genetic counseling services, Nucleus Genomics aims to redefine the genetic testing landscape, putting the capabilities of whole-genome sequencing directly into the hands of individuals and transforming the field of genomic medicine.

Who Are The Leading Firms Participating In The Neurogenomics Market?

Major companies operating in the neurogenomics market are F. Hoffmann-La Roche Limited, Thermo Fisher Scientific Incorporated, Danaher Corporation, Eurofins Scientific SE, Agilent Technologies Inc., Illumina Inc., Revvity Inc., QIAGEN N.V., Myriad Genetics Inc., GeneDx LLC, Fulgent Genetics Inc., Oxford Nanopore Technologies Plc, PacBio, MedGenome Labs Ltd., MGI Tech Co. Ltd., Centogene N.V., Variantyx Inc., BGI Genomics Co. Ltd., GenScript Biotech Corporation, Roche Diagnostics GmbH, Illumina Cambridge Ltd.

Access The Complete Neurogenomics Market Report:

https://www.thebusinessresearchcompany.com/report/neurogenomics-global-market-report

Which Region Is The Primary Market For The Neurogenomics Market?

North America was the largest region in the neurogenomics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the neurogenomics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Neurogenomics Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/customise?id=25845&type=smp

Browse Through More Reports Similar to the Global Neurogenomics Market 2026, By The Business Research Company

Genetic Testing Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/genetic-testing-global-market-report

Prenatal And Newborn Genetic Testing Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/prenatal-and-newborn-genetic-testing-global-market-report

Dna Testing Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/dna-testing-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795